跳至主要内容
临床试验/CTRI/2026/02/103629
CTRI/2026/02/103629尚未招募3 期

A randomised controlled clinical study to evaluate the efficacy of Kutaja Asanadi Yoga in the management of Prameha(prediabetes)

Dr Sagar Chilad1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年3月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1

研究概览

简要总结

Prediabetes is a condition characterized by elevated blood glucose levels below the threshold for a diagnosis of diabetes but associated with a higher risk of developing diabetes with or without clinical symptoms like fatigue, increased thirst, frequent urination, frequent thirst .Alongside Impaired glucose tolerance[140–199 mg/dL] and impaired fasting glucose[110–125 mg/dL] as per World Health Organization are commonly used to define prediabetes. which can be correlated with Prameha.

According to the principles of Ayurveda sedentary lifestyle, obesity, unrestricted diet are leading cause of Prameha and is explained as one of the Astamahagada with symptoms Madhuryamasya, Swedadikyata, Galatalusosha, karapadadaha, prabhutavilmutrata, trishnakshudhaadikya. If neglected turns to Madhumeha (further complication). Hence Early intervention at Purvaavastha of Prameha i.e prediabetic stage would help to slow progression towards diabetes.

In Contemporary medicine and drug therapy, Metformin is used as first line medicine therapy agent in prediabetes which showed to have side effects like gastrointestinal adverse events, weight loss, B12 deficiency etc. Here is an attempt to evaluate the outcome of Kutaja asanadi yoga which is having properties like kaphapitta shamak, Deepana, Pachana, Lekhana, Kledahara and Pramehahara, which is cost effective with easily available ingredients and its efficacy is compared with control drug Nisha amalaki yoga.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Prediabetic Subjects with or without clinical presentation and Fasting Blood Glucose between 100mg per dl to 125mg per dl With 8 hours of fasting As per ADA guidelines.
  • 2 Subjects with or without family history of diabetes.
  • IDRScore by MDRF greater than or equal to 60 out of 100 indicating high risk 5.

排除标准

  • Known case of type 1 and type 2 Diabetes Mellitus.
  • Patients already on Antidiabetic Medication
  • Prediabetic patients with co-morbidities which are life threatening or interferes with the intervention.
  • Pregnancy or lactating women.

研究者

发起方
Dr Sagar Chilad
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Sagar Chilad

SDMTs AMC Post Graduation Centre Terdal

研究点 (1)

Loading locations...

相似试验